Cold Multi-Symptom Severe

Product NDC
55910-035
Requested package NDC
55910-035-08
11-digit product format
559100035
Labeler code
55910
Product ID
55910-035_90198df4-10a5-4957-98be-12236a357007
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
DOLGENCORP, LLC
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2005-08-04
Marketing end
2023-12-09
Substance
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Active strength
325 mg/1; mg/1; mg/1; mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage55910-03555910-035-08DDiscontinued by firm2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
DEXTROMETHORPHAN HYDROBROMIDEACTIVE INGREDIENT9D2RTI9KYHCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
GUAIFENESINACTIVE INGREDIENT495W7451VQCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
ACETAMINOPHENACTIVE MOIETY362O9ITL9DCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
DEXTROMETHORPHANACTIVE MOIETY7355X3ROTSCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
GUAIFENESINACTIVE MOIETY495W7451VQCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
CROSPOVIDONEINACTIVE INGREDIENT68401960MKCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30COLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ACOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
POLYVINYL ALCOHOLINACTIVE INGREDIENT532B59J990COLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
POVIDONESINACTIVE INGREDIENTFZ989GH94ECOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2COLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
TALCINACTIVE INGREDIENT7SEV7J4R1UCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPCOLD MULTI-SYMPTOM SEVERE DAY TIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) TABLET, FILM COATED [DOLGENCORP, LLC]3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
55910-035-08559100035082 BLISTER PACK in 1 CARTON (55910-035-08) > 12 TABLET, FILM COATED in 1 BLISTER PACK2 blister pack2005-08-042023-12-09NoNoCurrent